| [1] |
Li Yawei, Yang Shoubo, Yin Shuo, Li Wenbin, Chen Feng.
Clinical efficacy analysis of hetrombopag in the treatment of cancer therapy included thrombocytopenia for germ cell tumors
[J]. Journal of Capital Medical University, 2025, 46(3): 420-426.
|
| [2] |
Wang Jingwen, Li Zhenjun, Lyu Liangcheng, Yao Xiaoyu, Ding Ning.
B cell receptor signaling pathway and its therapeutic implications in B-cell lymphoma
[J]. Journal of Capital Medical University, 2025, 46(3): 436-441.
|
| [3] |
Zhang Wenxiu, Xiong Yang, Yu Minghang, Wang Xi.
Advances in the role of STAT3 in tumor immunology
[J]. Journal of Capital Medical University, 2025, 46(3): 442-447.
|
| [4] |
Zi Xiaohui, Xia Xue, Li jing, Zhang Xiaoli, Zhou Quan, Wang Anxin, Wang Yilong.
Advances in the application of antiplatelet therapy in intravenous thrombolysis for acute ischemic stroke patients
[J]. Journal of Capital Medical University, 2025, 46(2): 234-242.
|
| [5] |
Zhang Meng, Ma Yongxin, Jia Qiong , Zhang Dongwei, Zhang Xinhong, Xu Yaoming .
Clinical observation on the efficacy and safety of intravenous thrombolysis in the treatment of acute mild non-disabling ischemic stroke: a single-center retrospective observational study
[J]. Journal of Capital Medical University, 2025, 46(1): 56-62.
|
| [6] |
Qiao Yue, Li Chuanhui, Zhao Wenbo.
The current status and future directions of reperfusion therapy for acute ischemic stroke
[J]. Journal of Capital Medical University, 2025, 46(1): 68-70.
|
| [7] |
Zhou Yan, Wu Wei.
Ethenic Chinese scientist Chen Zhijian discovers the cGAS-STING signaling pathway that senses DNA for immune surveillance——the 2024 Lasker Basic Medical Research Awards
[J]. Journal of Capital Medical University, 2024, 45(5): 923-927.
|
| [8] |
Li Tiezheng, Xu Kaikai, Deng Yuqing, Wang Peihao, Qin Qi, Guo Kangshun, Wang Bingren, Chang Dong, Cui Yong.
Analysis of the efficacy and safety of PD-1 inhibitors combined with chemotherapy in neoadjuvant treatment of locally advanced non-small cell lung cancer
[J]. Journal of Capital Medical University, 2024, 45(4): 636-641.
|
| [9] |
Wu Zhaozhen, Zheng Hua, Sheng Shuyan, Zhang Quan, Zhang Hui, Li Jie, Lyu Jialin, Qian Zhe, Wang Shouzheng, Li Xi , Hu Ying.
Observation on the preliminary efficacy of neoadjuvant immunotherapy combined with chemotherapy in non-small cell lung cancer
[J]. Journal of Capital Medical University, 2024, 45(4): 642-648.
|
| [10] |
Xu Yuan, Liang Naixin, Liu Hongsheng.
Prognostic factors in neoadjuvant immunotherapy for non-small cell lung cancer:pathologic lymph node metastasis and primary tumor response
[J]. Journal of Capital Medical University, 2024, 45(4): 649-653.
|
| [11] |
Liu Yang, Yang Lei, Han Yi.
The predictive value of folate receptor-positive circulating tumor cells in patients with resectable stage Ⅲ squamous cell carcinoma after neoadjuvant chemotherapy combined with immunotherapy
[J]. Journal of Capital Medical University, 2024, 45(4): 654-659.
|
| [12] |
Wang Jusi, Song Weian, Di Shouyin, Liu Junqiang, Fan Boshi, Zhou Shaohua, Yue Caiying, Zhao Jiahua, Chen Siyu, Gong Taiqian.
Efficacy of neoadjuvant chemotherapy combined with immunotherapy in the treatment of stage Ⅲ non-small cell lung cancer
[J]. Journal of Capital Medical University, 2024, 45(4): 660-665.
|
| [13] |
Hao Zhuohong, Yun Duo, Zhang Ying, Li Huihui, Lin Haishan, Cui Yong, Zhao Lei.
Advances in research of perioperative immunotherapy for non-small cell lung cancer—advances in neoadjuvant immunotherapy
[J]. Journal of Capital Medical University, 2024, 45(4): 666-677.
|
| [14] |
Zhao Shaozhi, Cao Yong.
Somatic mutations in endothelial cells and cerebral vascular malformations
[J]. Journal of Capital Medical University, 2024, 45(3): 379-384.
|
| [15] |
Chen Zhiguang, Zhang Wei, He Wen.
Composite piezoelectric nanoparticles based on P(VDF-TrFE) for precise imaging and targeted therapy of glioma
[J]. Journal of Capital Medical University, 2023, 44(6): 912-920.
|